“…Although the HLA system has been studied in multiple sclerosis since the early 1970s, few studies have described the HLA system in NMO 6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22 . Several studies have associated specific HLA class II alleles with susceptibility to NMO 8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23 . Recent studies have shown a relationship between NMO and HLA class II, particularly for the DPB1*05:01, DRB1*03 and DRB1*16:02 alleles 7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22 .…”